| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | MOBILEYE N V AMSTELVEEN | 20,000 | 841,000 | 0.52% | ||
| 52 | CYRUSONE INC | 25,000 | 778,000 | 0.48% | ||
| 53 | TETRAPHASE PHARMACEUTICALS INC COM | 20,000 | 733,000 | 0.46% | ||
| 54 | ASSEMBLY BIOSCIENCES INC | 48,000 | 636,000 | 0.40% | ||
| 55 | INOVALON HLDGS INC COM CL A | 19,150 | 579,000 | 0.36% | ||
| 56 | CELLDEX THERAPEUTICS INC NEW | 20,000 | 557,000 | 0.35% | ||
| 57 | INVITAE CORP | 32,232 | 540,000 | 0.34% | ||
| 58 | Rexford Industrial Realty Inc | 32,691 | 517,000 | 0.32% | ||
| 59 | TRILLIUM THERAPEUTICS INC | 25,000 | 506,000 | 0.32% | ||
| 60 | STEADYMED LTD | 55,000 | 468,000 | 0.29% | ||
| 61 | DERMIRA INC COM | 25,965 | 399,000 | 0.25% | ||
| 62 | LION BIOTECHNOLOGIES INC COM | 31,200 | 378,000 | 0.24% | ||
| 63 | XENCOR INC COM | 22,140 | 339,000 | 0.21% | ||
| 64 | ONCOTHYREON INC COM N/C EFF 6/ | 200,000 | 326,000 | 0.20% | ||
| 65 | BIOAMBER INC | 150,000 | 239,000 | 0.15% | ||
| 66 | BOOT BARN HLDGS INC | 10,000 | 239,000 | 0.15% | ||
| 67 | SOLAREDGE TECHNOLOGIES INC | 10,000 | 219,000 | 0.14% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-15-000946, filed 2015.04.20).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
